MRPS12: A Mitochondrial Protein Target for Drug Development (G6183)

Target Name: MRPS12

NCBI ID: G6183

MRPS12

MRPS12: A Mitochondrial Protein Target for Drug Development

Mitochondrial Ribosomal Protein S12 (MRPS12), also known as Transcript Variant 1, is a protein that plays a crucial role in the regulation of gene expression in the mitochondria. It is a key component of the ribosome, the protein complex that synthesizes RNA in the cell, and it functions to ensure the proper reading of DNA sequences in the genetic code. Mutations in the MRPS12 gene have been linked to a range of cellular and neurological disorders, making it an attractive target for drug development.

The MRPS12 gene is located on chromosome 16 and encodes a protein of 1,204 amino acids. It is one of the most abundant genes in the mitochondria, making up approximately 15% of the ribosome. It is composed of a unique open reading frame (ORF) that is highly conserved across different species, with the exception of a small insertion at its beginning. The ORF consists of the following segments:

1.Conserved region: The first 20 amino acids of the ORF are highly conserved across different species, including humans. This region includes a central alpha-helic acid loop, which is important for stability and stability of the ORF.
2. variable region: The variable region is the most variable part of the ORF and is responsible for the unique sequence of amino acids at its C-terminus. The variable region has been shown to play a role in the regulation of mitochondrial protein synthesis and has been implicated in a number of cellular processes, including the regulation of cell growth, cell death, and metabolism.
3. Stop codon: The third segment of the ORF is a series of three stop codons, which cause premature termination of the protein during synthesis.

The MRPS12 gene has been implicated in a number of diseases, including Alzheimer's disease, Parkinson's disease, and chronic myeloid leukemia. In particular, studies have linked mutations in the MRPS12 gene to the misfolding and aggregation of beta-amyloid peptides, which are a hallmark of Alzheimer's disease.

In addition to its role in the regulation of protein synthesis, MRPS12 has also been shown to play a role in the regulation of gene expression and cellular processes. It has been shown to interact with a number of different proteins, including Coiled-coil Transmembrane Proteins (TAPs), which are involved in the regulation of cellular processes such as cell adhesion, migration, and invasion.

Furthermore, MRPS12 has also been shown to play a role in the regulation of mitochondrial dynamics and metabolism. It has been shown to interact with Mitochondrial Proteins, which are involved in the regulation of mitochondrial function, and to contribute to the maintenance of mitochondrial homeostasis.

Given the unique role that MRPS12 plays in the regulation of gene expression and cellular processes, it is an attractive target for drug development. Studies have shown that a number of small molecules and compounds have been shown to interact with MRPS12 and to modulate its function. These compounds have been shown to have a wide range of therapeutic potential, including the treatment of Alzheimer's disease, Parkinson's disease, and chronic myeloid leukemia.

In conclusion, MRPS12 is a protein that has been shown to play a crucial role in the regulation of gene expression and cellular processes in the mitochondria. Its unique structure and the fact that it is composed of a highly conserved region and variable region make it an attractive target for drug development. The study of its functions and the use of small molecules and compounds to modulate its activity can provide valuable insights into the mechanisms of disease and the development of new treatments.

Protein Name: Mitochondrial Ribosomal Protein S12

The "MRPS12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MRPS12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets